MUC2 Expression Is Correlated with Tumor Differentiation and Inhibits Tumor Invasion in Gastric Carcinomas: A Systematic Review and Meta-analysis

다국어 초록 (Multilingual Abstract)

Background: While MUC2 is expressed in intestinal metaplasia and malignant lesions, the clinicopathological significance of MUC2 expression is not fully elucidated in gastric carcinoma (GC). Methods: The present study investigated the correlation between MUC2 expression and clinicopathological parameters in 167 human GCs. In addition, to confirm the clinicopathological significance of MUC2 expression, we performed a systematic review and meta-analysis in 1,832 GCs. Results: MUC2 expression was found in 58 of 167 GCs (34.7%). MUC2-expressing GC showed lower primary tumor (T), regional lymph node (N), and tumor node metastasis (TNM) stages compared with GCs without MUC2 expression (p = .001, p = .001, and p = .011, respectively). However, MUC2 expression was not correlated with Lauren’s classification and tumor differentiation. In meta-analysis, MUC2 expression was significantly correlated with differentiation and lower tumor stage (odds ratio [OR], 1.303; 95% confidence interval [CI], 1.020 to 1.664; p = .034 and OR, 1.352; 95% CI, 1.055 to 1.734; p = .017, respectively) but not with Lauren’s classification, pN stage, or pTNM stage. Conclusions: MUC2 expression was correlated with a lower tumor depth and lower lymph node metastasis in our study; the meta-analysis showed a correlation of MUC2 expression with tumor differentiation and lower tumor depth.

참고문헌 (Reference)

1 Barresi V, "Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren’s histologic subtypes of gastric carcinomas" 50 : 301-309, 2006

2 Kocer B, "Prognostic significance of mucin expression in gastric carcinoma" 49 : 954-964, 2004

3 Ïlhan Ö, "Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma" 21 : 345-352, 2010

4 김주연, "Microsatellite Instability Status in Gastric Cancer: A Reappraisal of Its Clinical Significance and Relationship with Mucin Phenotypes" 대한병리학회 47 (47): 28-35, 2013

5 Lee HS, "MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators" 92 : 1427-1434, 2001

6 Shiratsu K, "Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach" 105 : 126-133, 2014

7 Chang SK, "Localization of mucin(MUC2 and MUC3)messenger RNA and peptide expression in human normal intestine and colon cancer" 107 : 28-36, 1994

8 Busuttil RA, "Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis" 24 : 193-201, 2009

9 Reis CA, "Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression" 59 : 1003-1007, 1999

10 Zhang HK, "Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance" 10 : 3044-3047, 2004

11 Audie JP, "Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization" 41 : 1479-1485, 1993

12 Lee HW, "Expression of MUC2 in gastric carcinomas and background mucosae" 22 : 1336-1343, 2007

13 Akyürek N, "Expression of MUC1 and MUC2 mucins in gastric carcinomas : their relationship with clinicopathologic parameters and prognosis" 198 : 665-674, 2002

14 Utsunomiya T, "Expression of MUC1 and MUC2 mucins in gastric carcinomas : its relationship with the prognosis of the patients" 4 : 2605-2614, 1998

15 Baldus SE, "Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas" 79 : 133-138, 1998

16 Tanaka M, "Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy" 90 : 95-101, 2003

17 Li L, "Clinicopathological significance of mucin 2 immuno-histochemical expression in colorectal cancer : a meta-analysis" 24 : 190-195, 2012

18 Wakatsuki K, "Clinicopathological and prognostic significance of mucin phenotype in gastric cancer" 98 : 124-129, 2008

19 Gong L, "Bile acids initiate lineage-addicted gastroesophageal tumorigenesis by suppressing the EGF receptor-AKT axis" 2 : 286-293, 2009

20 Pyo JS, "Bile acid induces MUC2 expression and inhibits tumor invasion in gastric carcinomas" 2014

21 Wang RQ, "Alterations of MUC1 and MUC3 expression in gastric carcinoma : relevance to patient clinicopathological features" 56 : 378-384, 2003

22 Pyo JS, "Activation of nuclear factor-kappaB contributes to growth and aggressiveness of papillary thyroid carcinoma" 209 : 228-232, 2013